Clinical trial data shows that discontinuation of GLP-1 therapy typically results in return of appetite, food preoccupation, and weight regain, indicating that ongoing treatment may be necessary to maintain the reduction in food noise for many individuals
Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
Seeing my food intake has made a huge difference in my journey
Currently, intense media attention and influencer promotion, coupled with robust marketing tactics, have led to an increase in the demand for GLP-1 RAs, resulting in global shortages of these medications
Must be used according to applicable laboratory safety standards and regulatory requirements
In early February 2026, Hims launched a compounded oral semaglutide pill at $49, undercutting branded Wegovy